Savitz Ryan (CIK 1992324) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-10). Recent activity: Sell DNTH (8,224 shares), Buy DNTH (8,224 shares), Sell DNTH (20,000 shares), Buy DNTH (20,000 shares), Buy DNTH (20,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-10 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 8,224 | $738,844 |
| 2026-04-10 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Buy | 8,224 | $147,045 |
| 2025-12-05 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CFO & CBO | Sell | 20,000 | $903,600 |
| 2025-12-05 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CFO & CBO | Buy | 20,000 | $168,800 |
| 2025-09-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CFO & CBO | Buy | 20,000 | $168,800 |
| 2025-09-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CFO & CBO | Sell | 20,000 | $700,000 |
Source: SEC Form 4 filings · as of 2026-04-10